Alessandro Gronchi MD received his MD degree from Milan University (high honors) in 1992, and then completed his residency training in General Surgery at the San Raffaele General Hospital – Milan. During his residency he served for 2 years at the Italian Ministry of Foreign Affairs, working full time at the Lacor University Hospital in Gulu - Uganda. He then completed his training with a fellowship in Surgical Oncology at the National Cancer Institute – Milan – Italy in 1998. He visited Memorial Sloan Kettering Cancer Center in New York in 2002. He has been chair of the Sarcoma Service at the National Cancer Institute – Milan – Italy since 2001. He holds the National Scientific qualification for full professor of General Surgery. He runs the Sarcoma data base of the National Cancer Institute, which gathers clinical and biological information on over 10000 patients affected by soft tissue sarcoma (STS), desmoid-fibromatosis (DF) and GIST, treated over the past 3 decades in Milan. He is involved in all institutional research activities on sarcoma, which include neoadjuvant therapies in extremity and retroperitoneal sarcomas, new targets for specific STS subtypes, different telomere maintenance mechanisms in STS subtypes, genomic characterization of DF and mechanisms of resistance to therapy in GIST. He is the Principal Investigator of several Italian and International trials on STS, DF and GIST. He serves as member of the board of directors of the Italian Sarcoma Group (ISG), president of the Italian Society of Surgical Oncology (SICO) 2019-2021, member of the Sarcoma Disease Site Working Group of the Society of Surgical Oncology (SSO) 2018-2021, member of the board of directors of the European Society of Surgical Oncology (ESSO) 2020-2022; international representative on the executive council of the Society of Surgical Oncology (SSO) 2021-2023; member of the Sarcoma Task Force of the European Society for Medical Oncology (ESMO). He was chair of the EORTC Soft Tissue and Bone Sarcoma Group (2015-2017), president of the Connective Tissue Oncology Society (2016); international representative on the nominating committee of the Society of Surgical Oncology (2019-2020). He is member of the European Surgical Association (ESA), the American Society of Clinical Oncology (ASCO) and is honorary member of the Polish Society of Surgical Oncology (PSSO). He is one of the initiators of a global collaborative effort on retroperitoneal sarcoma (Trans-atlantic Australasian RetroPeritoneal Sarcoma Working Group, TARPSWG), which involves over 150 institutions worldwide. Dr Gronchi has authored more than 430 scientific publications (Scopus HIndex 77), serves as Associate Editor of the Journal of Surgical Oncology, Annals of Surgical Oncology, Critical Reviews in Oncology/Hematology, Tumori Journal, Sarcoma Journal, Clinical Sarcoma Research.

Dr Alessandro Gronchi has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies: